Sub-Acute Stroke Rehabilitation With AMES (AMES)
Sub-Acute Stroke Rehabilitation With Assisted Movement With Enhanced Sensation
Sponsor: AMES Technology
A NA clinical study on Cerebrovascular Stroke, this trial is completed. The trial is conducted by AMES Technology and has accumulated 9 data snapshots since 2007. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2023 — Jul 2024 [monthly]
Completed NA
-
Dec 2022 — Jan 2023 [monthly]
Completed NA
-
Nov 2022 — Dec 2022 [monthly]
Completed NA
Status: Unknown Status → Completed · Phase: PHASE2_PHASE3 → NA
▶ Show 4 earlier versions
-
Jan 2021 — Nov 2022 [monthly]
Unknown Status PHASE2_PHASE3
-
Jun 2018 — Jan 2021 [monthly]
Unknown Status PHASE2_PHASE3
-
Aug 2017 — Jun 2018 [monthly]
Unknown Status PHASE2_PHASE3
-
Jan 2017 — Aug 2017 [monthly]
Unknown Status PHASE2_PHASE3
First recorded
Sep 2007
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- AMES Technology
- Eisenhower Medical Center
- Emory University
- Legacy Health System
- Northwest Medical Rehabilitation, Spokane, WA
- Shirley Ryan AbilityLab
- University of California, San Francisco
For direct contact, visit the study record on ClinicalTrials.gov .